14 reports

TUBERCULOSIS VACCINE - DRUG PROFILE TUBERCULOSIS VACCINE - DRUG PROFILE TUBERCULOSIS VACCINE - DRUG PROFILE TUBERCULOSIS VACCINE - DRUG PROFILE TUBERCULOSIS VACCINE - DRUG PROFILE TUBERCULOSIS VACCINE - DRUG PROFILE tuberculosis vaccine

  • DNA
  • Tuberculosis
  • United States
  • World
  • Product Initiative

SMALL MOLECULES TO INHIBIT DNA GYRB FOR TUBERCULOSIS - DRUG PROFILE SMALL MOLECULES TO INHIBIT DNA GYRB FOR TUBERCULOSIS Drug Name Company/ Institute Name Licensed From Company Development Partner Product Description ASTRAZENECA PLC NA NA SMALL MOLECLES ARE UNDER DEVELOPMENT FO

  • Tuberculosis
  • United States
  • World
  • Product Initiative
  • Spero Therapeutics, LLC

Jun ##, 2013: WHO Issues Interim Guidance On Bedaquiline To Treat Multidrug-Resistant Tuberculosis The World Health Organization (WHO) issued interim guidance on the use of bedaquiline, a new tuberculosis drug, for the treatment of multidrug-resistant tuberculosis (MDR-TB)

  • Tuberculosis
  • United States
  • World
  • Product Initiative
  • Lycera Corp.

HG##-SeV is under development for the prevention of tuberculosis.

  • Tuberculosis
  • Vaccine
  • South Africa
  • World
  • Product Initiative

Jun ##, 2013: WHO Issues Interim Guidance On Bedaquiline To Treat Multidrug-Resistant Tuberculosis The World Health Organization (WHO) issued interim guidance on the use of bedaquiline, a new tuberculosis drug, for the treatment of multidrug-resistant tuberculosis (MDR-TB)

  • Antibiotic Resistance
  • Tuberculosis
  • World
  • Product Initiative
  • Lycera Corp.

TB/ FLU-##L - Drug Profile tuberculosis vaccine - Drug Profile tuberculosis vaccine - Drug Profile tuberculosis vaccine ## - Drug Profile Mycobacterium tuberculosis Protein Ag##A - Dormant Projects Mycobacterium tuberculosis Protein Ag##A - Discontinue

  • Tuberculosis
  • Vaccine
  • South Africa
  • World
  • Product Initiative

TUBERCULOSIS.

  • Research And Development
  • Tuberculosis
  • World
  • Product Initiative
  • TB Drug Development, Inc.

It offers TG## and various candidates for chronic hepatitus B and tuberculosis.

  • Genetically Modified Organism
  • Therapy
  • Transgene
  • Tuberculosis
  • Transgene SA

Other Developmental Activities AN-## Product Description Small Molecule ## for Tuberculosis Product Description Small molecule is under development for the treatment of tuberculosis.

  • Pharmaceutical
  • Tuberculosis
  • World
  • Product Initiative
  • Anacor Pharmaceuticals, Inc.

V## inherently contains circulating M. tuberculosis antigens.

  • Pathology
  • Tuberculosis
  • World
  • Product Initiative
  • Immunitor, Inc.

Mechanism of Action GlobeImmune, Inc. is developing GI-## for the prevention of tuberculosis.

  • Tuberculosis
  • United States
  • World
  • Product Initiative
  • GlobeImmune, Inc.

R& D Progress Research and Development Brief Discovery/ Preclinical Trial Details Small Molecule ## for Tuberculosis Product Description Small molecule for tuberculosis is under development for the treatment of tuberculosis.

  • Infectious Disease
  • Therapy
  • Tuberculosis
  • United States
  • Sanofi S.A.

NITD-## elicits anti-tuberculosis activity by inhibiting MmpL## protein.

  • Cancer
  • Targeted Therapy
  • Therapy
  • Tuberculosis
  • Novartis AG

The scientists reported ##, ##-azaindoles as a new inhibitor class that killed Mycobacterium tuberculosis in vitro and demonstrated efficacy in mouse tuberculosis models.

  • Cancer
  • Therapy
  • Tuberculosis
  • United States
  • AstraZeneca PLC